AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) to Present at the UBS Annual Global Life Sciences Conference

Published: Sep 13, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ: AVEO) today announced that David Johnston, chief financial officer, is scheduled to present at the UBS Annual Global Life Sciences Conference on Thursday, September 20, 2012 at 2:00 p.m. (ET) in New York City.

Back to news